CEPI, the Coalition for Epidemic Preparedness Innovations, has announced a collaboration with South Korea-based SK Bio...
On the basis of scientific advice, the Australian Government has secured an additional 20 million doses of the promising...
Sinovac Biotech Ltd, a leading provider of biopharmaceutical products in China, has announced that the China National Me...
Singapore, like any other country, understands that the successful development of safe and efficacious vaccines is ...
Malaysia has announced funding of $3 million to the Coalition for Epidemic Preparedness Innovations (CEPI) to help suppo...
Sinovac Biotech Ltd, a leading provider of biopharmaceutical products in China, has announced that Sinovac Life Sciences...
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect peop...
The International Vaccine Institute (IVI) and South Korean company EuBiologics exchanged an MOU to cooperate in the clin...
Vaccine confidence has never been more important, as the world waits for the first COVID-19 protection options to move t...
Pfizer Inc. and BioNTech SE have announced that the Medicines & Healthcare Products Regulatory Agency (MHR...
BioNTech SE and Pfizer Inc. on 30 Nov 2020 have submitted a formal Application for Conditional Marketing ...
The government of the Republic of Korea (ROK) has decided to contribute $3 million in 2020 for the first time to the Coa...
Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vacci...
The International Vaccine Institute (IVI) and Ministry of Foreign Affairs and Human Mobility of Ecuador exchanged a memo...
The cost of one dose of the Sputnik V vaccine for international markets will be less than $10. Sputnik V is a ...
The International Vaccine Institute (IVI) and the Vaccine Innovative Technology ALliance Korea (VITAL-Korea) agreed to j...
Hester Nepal recently got the regulatory approval and marketing authorisation from Department of Drug Administration (DD...
To rapidly monitor the emergence of new COVID-19 viral strains and evaluate their impact on vaccine candidates in develo...
Pfizer Inc. and BioNTech have announced that, after conducting the final efficacy analysis in their ongoing Ph...
US-based Cytiva, a global life sciences leader, is supporting Shanghai-based Clover Biopharmaceuticals, a global clinica...
The Australian government has announced that the largest flu vaccine manufacturing plant in the southern hemisphere will...
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and GL Rapha, one of the leading South ...
Arcturus Therapeutics Holdings Inc., based in the US, has announced positive interim clinical study results from its ong...
Pfizer Inc. and BioNTech SE have announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV...
Two more COVID-19 vaccines have been secured for the Australian population under new agreements, bringing the Australian...
